Unconfigured Ad

Collapse
X
 
  • Filter
  • Time
  • Show
Clear All
new posts
  • abakelaar
    Member
    • Jul 2011
    • 10

    auto_annovar

    can anyone tell me what's wrong


    [abakelaar@iPipeline annovar]$ perl auto_annovar.pl -model recessive 0004_61WDG_s_5 humandb/hg18/ --buildver hg18 NOTICE: the --ver1000g argument is set as '1000g' by default

    NOTICE: Running step 1 with system command <annotate_variation.pl -geneanno -buildver hg18 -dbtype refgene -outfile 0004_61WDG_s_5.step1 0004_61WDG_s_5 humandb/hg18/>
    Can't exec "annotate_variation.pl": No such file or directory at auto_annovar.pl line 131.
    Error running system command: <annotate_variation.pl -geneanno -buildver hg18 -dbtype refgene -outfile 0004_61WDG_s_5.step1 0004_61WDG_s_5 humandb/hg18/>
  • scd
    Junior Member
    • Mar 2011
    • 2

    #2
    Annovar requires that the annotate_variation.pl script is somewhere in your global execution path.

    What I've done is make a symbolic link in /usr/local/bin that points to the annotate_variation.pl script.

    Use ln -s to do so (http://unixhelp.ed.ac.uk/CGI/man-cgi?ln)

    Comment

    • tmacme
      Junior Member
      • Oct 2011
      • 3

      #3
      Hey guy,
      When I finished making the "symbolic link" as you indicated , the "Error running system command" message was still there ,with the message "Can't exec "annotate_variation.pl" missed. And now I was so confused.
      [ps] I use Cygwin.

      Comment

      Latest Articles

      Collapse

      • SEQadmin2
        Proteomic Platforms: How to Choose the Right Analytical Strategy to Improve Detection and Clinical Applications
        by SEQadmin2


        Proteomics platforms are evolving rapidly, with advances in mass spectrometry and affinity-based approaches expanding what researchers can detect and at what scale. As the field moves toward deeper proteome coverage and clinical applications, scientists face an increasingly complex landscape of tools. This article will explore how researchers are navigating these choices to find the right platform for their work.

        The systematic characterization of the human proteome has
        ...
        07-20-2026, 11:48 AM
      • SEQadmin2
        Advanced Sequencing Platforms Tackle Neuroscience’s Toughest Genomics Problems
        by SEQadmin2



        Genomics studies in neuroscience face a special challenge due to the brain’s complexity and scarcity of samples. Mapping changes in cell type and state using conventional next-generation sequencing methods remains challenging. Advances in technologies like single-cell sequencing, spatial transcriptomics, and long-read sequencing have opened the door to deeper studies of the brain and diseases like Alzheimer’s, amyotrophic lateral sclerosis (ALS), and schizophrenia.
        ...
        07-09-2026, 11:10 AM
      • SEQadmin2
        Cancer Drug Resistance: The Lingering Barrier to Rising Survival
        by SEQadmin2



        Cancer survival rates have significantly increased in the last few decades in the United States, reaching a combined 70% 5-year survival rate by 2021. Behind this number, there are years of research to find new therapies, drug targets, and early detection methods. But there is one core challenge that keeps slowing down these advances, and it’s about drug resistance.

        There is no single reason why many patients don’t respond to treatment as expected. Cancer is...
        07-08-2026, 05:17 AM

      ad_right_rmr

      Collapse

      News

      Collapse

      Topics Statistics Last Post
      Started by SEQadmin2, Yesterday, 12:17 PM
      0 responses
      13 views
      0 reactions
      Last Post SEQadmin2  
      Started by SEQadmin2, 07-23-2026, 11:41 AM
      0 responses
      14 views
      0 reactions
      Last Post SEQadmin2  
      Started by SEQadmin2, 07-20-2026, 11:10 AM
      0 responses
      23 views
      0 reactions
      Last Post SEQadmin2  
      Started by SEQadmin2, 07-13-2026, 10:26 AM
      0 responses
      37 views
      0 reactions
      Last Post SEQadmin2  
      Working...